05.21.24
A CoQ10 ingredient marketed by Kaneka Nutrients Europe as Ubiquinol appeared to alleviate self-reported symptoms of menopause in the majority of 200 women who took part in a consumer survey. About 80% of participants experienced improvements, particularly when it came to psychological and emotional health, after two months of daily supplementation with 200 mg of the ingredient daily.
The study was carried out by a French research institute Expansion Consulteam earlier this year, in collaboration with lifestyle influencers Virginie Florin and Nathalie Simon, who helped to recruit 200 female participants between the ages of 45 and 55 via Instagram live stream.
Women who were included experienced menopause discomfort rated at least five on a scale of one to 10 in domains including emotional imbalance, quality of life, stress, sleep, muscle aches, and pains. Women were excluded if they were receiving hormone treatment, non-drug therapy, supplements for menopause, herbal medicine, homeopathy, medicine, or topical therapy.
At baseline, there was high prevalence and intensity of menopause symptoms among the participants, including poor skin quality (94% of participants), sleep disturbances (90%), and stress/anxiety (85%).
Eighty percent of participants found that Ubiquinol was effective in alleviating symptoms, and reported reduced stress, irritability, and sensitivity over the two-month period. That same amount of participants reported an improvement in mood and felt “more emotionally stable” within 30 days of supplementation, and 70% reported improved sleep quality, less muscular pain, and improved wellbeing by the end of the study period. By 30 days, 76% of participants said they felt the full effects of supplementation, and eight of 10 participants said they’d recommend it as a solution for other women experiencing menopause.
“Everyone with a menstrual cycle will go through menopause during their lifetime, and by 2025, it is estimated that there will be 1.1 billion postmenopausal women worldwide. Once considered a taboo topic, consumers are now beginning to talk more openly about the effects of menopause. And with 50% of women saying that their menopause symptoms have impacted their home life, it’s important that they have the solutions they need to live life to the full,” said Filip Van hulle, general manager, Kaneka Nutrients Europe. “These findings present an exciting new opportunity for brands to offer new solutions for women experiencing menopause. Now, we look forward to collaborating with our partners to empower women throughout all stages of life.”
The study was carried out by a French research institute Expansion Consulteam earlier this year, in collaboration with lifestyle influencers Virginie Florin and Nathalie Simon, who helped to recruit 200 female participants between the ages of 45 and 55 via Instagram live stream.
Women who were included experienced menopause discomfort rated at least five on a scale of one to 10 in domains including emotional imbalance, quality of life, stress, sleep, muscle aches, and pains. Women were excluded if they were receiving hormone treatment, non-drug therapy, supplements for menopause, herbal medicine, homeopathy, medicine, or topical therapy.
At baseline, there was high prevalence and intensity of menopause symptoms among the participants, including poor skin quality (94% of participants), sleep disturbances (90%), and stress/anxiety (85%).
Eighty percent of participants found that Ubiquinol was effective in alleviating symptoms, and reported reduced stress, irritability, and sensitivity over the two-month period. That same amount of participants reported an improvement in mood and felt “more emotionally stable” within 30 days of supplementation, and 70% reported improved sleep quality, less muscular pain, and improved wellbeing by the end of the study period. By 30 days, 76% of participants said they felt the full effects of supplementation, and eight of 10 participants said they’d recommend it as a solution for other women experiencing menopause.
“Everyone with a menstrual cycle will go through menopause during their lifetime, and by 2025, it is estimated that there will be 1.1 billion postmenopausal women worldwide. Once considered a taboo topic, consumers are now beginning to talk more openly about the effects of menopause. And with 50% of women saying that their menopause symptoms have impacted their home life, it’s important that they have the solutions they need to live life to the full,” said Filip Van hulle, general manager, Kaneka Nutrients Europe. “These findings present an exciting new opportunity for brands to offer new solutions for women experiencing menopause. Now, we look forward to collaborating with our partners to empower women throughout all stages of life.”
